There was a research that was conducted by the FDA (Food and Drug Administration) and Health Canada. Both these agencies thoroughly reviewed the drug called YAZ which is a contraceptive that was prescribed to women to avoid pregnancy. The study was done to confirm the hypothesis that usage of the drug increases the risk of blood clots in women when compared to other birth control pills in the market. Besides this, the drug was already associated with some of the most life-threatening side-effects. The research concluded that the presence of progestin drospirenone in the YAZ drug increased the yaz blood clot risk in women significantly. Together with this, it also increased the risk of venous thromboembolism when compared to other birth control pills that had a combination of progestin mixed with oestrogen. These results were released after the British Medical Journal reported them and the necessary actions required are being pondered upon.

(Sponsored Attorney Advertising)